USD10
EVMN Shares
About EvommuneEvommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
USD10
EVMN Shares
About EvommuneEvommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Stats
TRADING WINDOW
Closed
OPENS AT
May 11 at 1:30 PM GMT+0
MARKET CAP
$834.55M
OPEN PRICE
$23.86
LOW (1Y)
$13.89
HIGH (1Y)
$33.20
LOW (24H)
$23.09
HIGH (24H)
$24.88
VOLUME (24H)
$623.91K
50.88%
Price history
Time | Price | Change |
|---|---|---|
Today | $23.86 | |
1 Day | $22.89 | |
1 Week | $23.63 | |
1 Month | $25.97 | |
1 Year | $20.23 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
